Medical News

RSS

Phase II psoriasis study shows efficacy of Boehringer Ingelheim's BI 655066 over ustekinumab

New results from a Phase II head-to-head psoriasis study showed superior efficacy of Boehringer Ingelheim's investigational biologic compound BI 655066, over ustekinumab. After nine months, 69 percent of patients with moderate-to-severe plaque psoriasis maintained clear or almost clear skin (PASI 90) with BI 655066 in the higher dose group compared to 30 percent of patients on ustekinumab.

8 Oct 2015

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

Allergan plc today announced that its infectious disease portfolio will be featured in 13 abstracts highlighting data at IDWeek 2015, which takes place from October 7-11, 2015, in San Diego.

8 Oct 2015

AcelRx provides update on Zalviso (sufentanil sublingual tablet system)

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a regulatory update on Zalviso (sufentanil sublingual tablet system) intended for the management of moderate-to-severe acute pain in adult patients in the hospital setting.

8 Oct 2015

Study assesses customer satisfaction with blood glucose meters

Training materials that are accessible and easy to understand contribute to an overall increase in satisfaction among adults or parents of children with Type 1 or Type 2 diabetes who use a blood glucose meter, and satisfaction is significantly higher when they understand how to use their meter, according to the J.D. Power 2015 U.S. Blood Glucose Meter Satisfaction Study.

8 Oct 2015

Research: Many Americans use prescription pain relievers, most people see abuse as serious health issue

More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.

8 Oct 2015

Lund researchers one step closer to developing implantable electrodes for capturing brain function

For nearly nine years, researchers at Lund University have been working on developing implantable electrodes that can capture signals from single neurons in the brain over a long period of time - without causing brain tissue damage. They are now one big step closer to reaching this goal, and the results are published in the scientific journal Frontiers in Neuroscience.

8 Oct 2015

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that data from a pilot study for its H.P. Acthar Gel (repository corticotropin injection) will be presented at the American College of Rheumatology 2015 Annual Meeting to be held November 7-11 in San Francisco.

8 Oct 2015

Boston Scientific closes additional financing with MValve Technologies

Boston Scientific Corporation today announced that it has closed on an additional round of financing with MValve Technologies Ltd., a developer of a percutaneous mitral valve replacement system, designed to work with the Boston Scientific LOTUS Valve, creating a unique mitral regurgitation (MR) treatment solution.

8 Oct 2015

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that NBI-98854, a highly selective small molecule VMAT2 inhibitor, showed a statistically significant reduction in tardive dyskinesia during the six weeks of placebo-controlled treatment in the Kinect 3 clinical trial. This Phase III trial included moderate to severe tardive dyskinesia patients with underlying schizophrenia, schizoaffective disorder, bipolar or major depressive disorder.

8 Oct 2015

Bionomics, Merck extend collaboration to develop drug candidates for treatment of chronic and neuropathic pain

Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today announced that it has extended its strategic collaboration with Merck & Co., Inc., Kenilworth NJ., (known as MSD outside the United States and Canada) for the discovery and development of drug candidates for the treatment of chronic and neuropathic pain.

8 Oct 2015

Blackstone enters into definitive agreement to acquire BioMed Realty for $8 billion

BioMed Realty Trust, Inc. today announced that it has entered into a definitive agreement with affiliates of Blackstone Real Estate Partners VIII, under which Blackstone will acquire all outstanding shares of common stock of BioMed Realty for $23.75 per share in an all-cash transaction valued at $8 billion.

8 Oct 2015

Study shows men and women react very differently to various types of infidelity

If your partner has sex with someone else, it is considered infidelity - even if no emotions are involved. But it is also considered infidelity when your significant other develops a close personal relationship with someone else, even if there is no sex or physical intimacy involved.

8 Oct 2015

Immune-molecule-based mop-up therapy reduces specific type of breast tumor in mice

Disabling a cancer-causing pathway and administering an immune-molecule-based mop-up therapy eradicated a specific type of breast tumor in mice, according to researchers in the Perelman School of Medicine at the University of Pennsylvania.

8 Oct 2015

Medtronic unveils next-generation version of superDimension lung navigation system software

Further underscoring its ongoing commitment to lung health, Medtronic today unveiled a next-generation version of its superDimension navigation system software. The superDimension navigation system enables a minimally invasive approach to access difficult-to-reach areas of the lung, and can aid in the diagnosis of lung diseases.

8 Oct 2015

Mental disorders could be underlying risk factors for chronic pain in children and young people

One in four young people have experienced chronic pain and a mental disorder. According to a new report in the Journal of Pain, the onset of pain is often preceded by mental disorders: an above-average rate of incidence of depression, anxiety disorders, and behavioral disorders occurs before the onset of headaches, back pain and neck pain.

8 Oct 2015

Researchers create on-screen models of patient's beating heart

With the patient's heart displayed on a screen, cardiac specialists and engineers can run simulations of a variety of surgical procedures and predict their effects prior to an operation. This will save lives.

8 Oct 2015

Researchers identify completely new information on how cancer cells internally transmit signals

A new study from the University of Turku, Finland, shows that intracellular receptor signalling sustains cancer cells that have detached from the surrounding tissue. When the signalling is prevented, the cells cannot spread to other parts of the body. This significant research result influences how cancer research is directed in the future.

8 Oct 2015

Invasive Salmonella infections revealed as major cause of child illness and deaths in Africa

Invasive Salmonella infections in sub-Saharan Africa are a major cause of child illness and deaths, a new body of research into this usually overlooked infectious disease has revealed.

8 Oct 2015

Gut microbiome can play significant role in the body's response to gluten

Investigators interested in celiac disease, a chronic gastrointestinal disorder caused by an immunologic response to the ingestion of gluten, have wondered why only 2% to 5% of genetically susceptible individuals develop the disease.

8 Oct 2015

Poll: Americans across political spectrum support presidential debate on science-based challenges

An overwhelming majority of Americans (87%) say it is important that candidates for President and Congress have a basic understanding of the science informing public policy issues, including majorities across the political spectrum (92% of Democrats, 90% of Republicans and 79% of Independents).

8 Oct 2015

Medical News

Phase II psoriasis study shows efficacy of Boehringer Ingelheim's BI 655066 over ustekinumab

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

AcelRx provides update on Zalviso (sufentanil sublingual tablet system)

Study assesses customer satisfaction with blood glucose meters

Research: Many Americans use prescription pain relievers, most people see abuse as serious health issue

Lund researchers one step closer to developing implantable electrodes for capturing brain function

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Boston Scientific closes additional financing with MValve Technologies

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Bionomics, Merck extend collaboration to develop drug candidates for treatment of chronic and neuropathic pain

Blackstone enters into definitive agreement to acquire BioMed Realty for $8 billion

Study shows men and women react very differently to various types of infidelity

Immune-molecule-based mop-up therapy reduces specific type of breast tumor in mice

Medtronic unveils next-generation version of superDimension lung navigation system software

Mental disorders could be underlying risk factors for chronic pain in children and young people

Researchers create on-screen models of patient's beating heart

Researchers identify completely new information on how cancer cells internally transmit signals

Invasive Salmonella infections revealed as major cause of child illness and deaths in Africa

Gut microbiome can play significant role in the body's response to gluten

Poll: Americans across political spectrum support presidential debate on science-based challenges

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News